• 1. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?
  Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455
• 2. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 3. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 4. An ion-gating multinanochannel system based on a copper-responsive self-cleaving DNAzyme?
  Yang Chen,Di Zhou,Zheyi Meng,Jin Zhai Chem. Commun., 2016,52, 10020-10023
• 5. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Bromobenzenes
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Halobenzenes Bromobenzenes

Compound CAS No. 1388095-52-0: (1S,3R)-3-(4-Bromophenyl)cyclopentanamine

The compound (1S,3R)-3-(4-Bromophenyl)cyclopentanamine, identified by the CAS number 1388095-52-0, is a significant molecule in the field of organic chemistry and drug discovery. This compound belongs to the class of cyclopentanamines, which are widely studied for their potential applications in pharmacology and materials science. The structure of this molecule features a cyclopentane ring substituted with an amino group at position 1 and a bromophenyl group at position 3, with specific stereochemistry designated as (1S,3R). This stereochemistry plays a crucial role in determining the compound's physical properties, reactivity, and biological activity.

Recent advancements in synthetic chemistry have enabled the efficient synthesis of (1S,3R)-3-(4-Bromophenyl)cyclopentanamine. Researchers have employed various strategies, including asymmetric catalysis and enantioselective synthesis, to produce this compound with high optical purity. The use of chiral auxiliaries and transition metal catalysts has significantly improved the yield and enantiomeric excess in the synthesis process. These methods not only enhance the scalability of production but also pave the way for its application in drug development.

In terms of biological activity, (1S,3R)-3-(4-Bromophenyl)cyclopentanamine has shown promising results in preclinical studies. It exhibits selective binding to certain G-protein coupled receptors (GPCRs), making it a potential candidate for treating conditions such as chronic pain and inflammation. Recent studies have highlighted its ability to modulate neurotransmitter release, which could be beneficial in neurodegenerative diseases like Alzheimer's. The bromine substituent at the para position of the phenyl ring contributes to its unique pharmacokinetic profile, including improved solubility and bioavailability.

The stereochemistry of this compound is particularly important for its biological activity. The (1S,3R) configuration ensures proper alignment of functional groups for receptor binding, which is critical for therapeutic efficacy. Researchers have utilized computational modeling techniques, such as molecular docking and dynamics simulations, to understand the interaction between this compound and its target proteins. These studies provide valuable insights into optimizing its structure for enhanced potency and selectivity.

In addition to its pharmacological applications, (1S,3R)-3-(4-Bromophenyl)cyclopentanamine has been explored for its potential in materials science. Its rigid cyclopentane ring and substituted groups make it a suitable candidate for designing novel polymers and nanomaterials. Recent research has demonstrated its ability to form self-assembled monolayers with tailored surface properties, which could be useful in sensor technology and drug delivery systems.

The synthesis of this compound involves multiple steps, starting from readily available starting materials such as cyclopentanone and bromobenzene derivatives. Key steps include alkylation reactions, reduction processes, and stereochemical control during intermediate formation. The use of advanced analytical techniques like NMR spectroscopy and X-ray crystallography ensures precise characterization of the final product.

From an environmental perspective, the production and handling of (1S,3R)-3-(4-Bromophenyl)cyclopentanamine must adhere to strict safety protocols due to its chemical nature. Although it is not classified as a hazardous substance under current regulations, proper disposal methods are recommended to minimize ecological impact.

In conclusion, (1S,3R)-3-(4-Bromophenyl)cyclopentanamine (CAS No. 1388095-52-0) represents a versatile molecule with diverse applications across multiple scientific disciplines. Its unique structure, stereochemistry-dependent activity, and potential for further modification make it an exciting subject for ongoing research efforts. ]]>

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)